Catalyst
Slingshot members are tracking this event:
BioMarin's (BMRN) BLA Approved by FDA for Brineura (Cerliponase Alfa) in Treatment of Batten Disease
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| BMRN |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 27, 2017
Occurred Source:
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm555613.htm
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Brineura, Pdufa, Biologics License Application, Bla, Cerliponase Alfa, Batten Disease
